Drugmakers Reroute Medical Supplies via Saudi Arabia Amid Gulf War Disruptions
Saudi Arabia has become a critical logistical hub for pharmaceutical companies seeking to maintain medicine supplies to Gulf states amidst ongoing conflict with Iran. With major regional cargo hubs like Dubai, Abu Dhabi, and Doha closed due to drone and missile attacks, Riyadh and Jeddah airports remain operational. Medicines are now being flown into Saudi Arabia and transported by road to neighboring countries. This disruption poses severe risks to patients, particularly those requiring cancer treatments and other temperature-sensitive drugs with short shelf lives. Experts warn that medical facilities could face critical shortages within four to six weeks if the situation persists. While some cargo is being rerouted through Istanbul, Oman, China, or Singapore, establishing new cold-chain corridors is complex and time-consuming. Sea routes are deemed impractical due to longer transit times and the closure of the Strait of Hormuz. Industry executives are prioritizing patient-critical shipments and mapping existing logistics to mitigate delays, but the interruption of over twenty percent of global air cargo routes in the region continues to threaten healthcare stability across the Middle East.
Wire timeline
Drugmakers Reroute Medical Supplies via Saudi Arabia Amid Gulf War Disruptions
Saudi Arabia has become a critical logistical hub for pharmaceutical companies seeking to maintain medicine supplies to Gulf states amidst ongoing conflict with Iran. With major regional cargo hubs like Dubai, Abu Dhabi, and Doha closed due to drone and missile attacks, Riyadh and Jeddah airports remain operational. Medicines are now being flown into Saudi Arabia and transported by road to neighboring countries. This disruption poses severe risks to patients, particularly those requiring cancer treatments and other temperature-sensitive drugs with short shelf lives. Experts warn that medical facilities could face critical shortages within four to six weeks if the situation persists. While some cargo is being rerouted through Istanbul, Oman, China, or Singapore, establishing new cold-chain corridors is complex and time-consuming. Sea routes are deemed impractical due to longer transit times and the closure of the Strait of Hormuz. Industry executives are prioritizing patient-critical shipments and mapping existing logistics to mitigate delays, but the interruption of over twenty percent of global air cargo routes in the region continues to threaten healthcare stability across the Middle East.
Middle-East